10x Genomics, Inc. (LON:0A88)
London · Delayed Price · Currency is GBP · Price in USD 18.16
+0.10 (0.55%)
At close: Dec 4, 2025
10x Genomics Revenue
10x Genomics had revenue of $149.00M USD in the quarter ending September 30, 2025, a decrease of -1.75%. This brings the company's revenue in the last twelve months to $641.81M, up 1.92% year-over-year. In the year 2024, 10x Genomics had annual revenue of $610.79M, down -1.28%.
Revenue (ttm)
$641.81M
Revenue Growth
+1.92%
P/S Ratio
3.54
Revenue / Employee
$491.43K
Employees
1,306
Market Cap
1.69B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 610.79M | -7.94M | -1.28% |
| Dec 31, 2023 | 618.73M | 102.32M | 19.81% |
| Dec 31, 2022 | 516.41M | 25.92M | 5.28% |
| Dec 31, 2021 | 490.49M | 191.65M | 64.13% |
| Dec 31, 2020 | 298.85M | 52.95M | 21.53% |
| Dec 31, 2019 | 245.89M | 99.58M | 68.06% |
| Dec 31, 2018 | 146.31M | 75.23M | 105.83% |
| Dec 31, 2017 | 71.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |